Drugs / GLPG0187 prodrug
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01580644 | Jan → Mar 2012 | — | Lakefront Biotherapeutics NV | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GLPG0187 prodrug | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01580644 ↗ |
| Known as | Isopropyl Malonate Prodrug of GLPG0187 | “Bioavailability Study of Two Formulations of the Isopropyl Malonate Prodrug of GLPG0187 in Healthy Male Subjects” NCT01580644 ↗ |
| Route | Oral | “after a single oral dose of the prodrug of GLPG0187 given to healthy subjects.” NCT01580644 ↗ |